Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011849 (diabetes)
 277,896 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

AIDA is a prototype computer system that incorporates a model of glucose-insulin interaction in type I diabetes mellitus alongside a knowledge-based system to make glycaemic predictions and to generate insulin dosage adjustment advice. The model attempts to reflect the underlying (patho)physiology of insulin action and carbohydrate absorption in quantitative terms. The prototype is intended to be used as a decision support system by clinical personnel in the context of day-to-day management of insulin-dependent diabetic patients. It is designed for use during consultations, as a simulator of patient response following changed insulin and dietary regimen and as a system for providing education on planning insulin therapy. Joe Daniels is a 41-year-old, 70-kg, male insulin-dependent diabetic patient who was diagnosed as being diabetic in 1972, at the age of 22. Joe recently found that he was having hypoglycaemic symptoms. Using self-monitoring blood glucose equipment, glycaemic levels below 3.0 mmol/l were recorded at least once a week, while hyperglycaemic readings (> 16 mmol/l) were observed two to three times per week. Joe came into hospital to have his glycaemic control improved, as doctors were concerned about the risks of him suffering a serious hypoglycaemic attack. Using some of the data collected by Joe while in hospital, we will demonstrate how AIDA might be applied either in a clinical setting to provide therapeutic advice or in an educational setting to interactively teach diabetic patients about their diabetes and educate them to adjust their own insulin injections and diet.
 ...
PMID:AIDA: an interactive diabetes advisor. 818 65

This paper overviews the Internet release of AIDA, a freeware interactive educational diabetes simulator. Since its release on the World Wide Web as a non-commercial contribution to continuing diabetes education over 14,000 people have visited the AIDA Web site--http:/(/)www.diabetic.org.uk/aida.htm--and over 5000 copies of the program have been downloaded, without charge. User responses thus far have been very encouraging. Example feedback and clinical experience reported by two insulin-dependent (type 1) diabetic patients, a patient's carer, the father of a diabetic teenager, a diabetes doctor and nurse educator, an endocrinologist and a postgraduate educator are presented. While such anecdotal, qualitative assessments are worthwhile and form a necessary step in the overall evaluation process--they are clearly subjective in nature and fully recognised as such. Given this, definitive outcome measures are highlighted as being required for the next stage in the evaluation process, and various objective evaluation criteria are proposed. A general protocol for the evaluation of interactive educational simulation tools, like AIDA, with patients is described and the concept of applying this in multiple centres--as a way of increasing study sample sizes--is discussed. It is highlighted that such a protocol could also be used to objectively compare a number of different interactive educational diabetes simulators. Clinicians who are interested in collaborating by enrolling patients into such a study are invited to contact the author, by email, at aida@globalnet.co.uk
 ...
PMID:Preliminary experience with the Internet release of AIDA--an interactive educational diabetes simulator. 970 Apr 27

In 1996 an interactive educational diabetes simulator called AIDA was released without charge on the Internet as a non-commercial contribution to continuing diabetes education. Over the past 3 years over 30,000 people have visited the AIDA Web site-- http://www.diabetic.org.uk/aida.htm--and over 10,000 copies of the program have been downloaded from there free-of-charge. This review builds on the experience gained from the AIDA development and the World Wide Web distribution of the software, and looks to the future, highlighting features which users might expect to see in future generations of such interactive educational diabetes programs. Novel functions already described in the literature are overviewed, and possible applications using personal computers and the Internet are discussed. The importance of the user interface is stressed. The concept of a "virtual diabetic patient" that provides an electronic representation of a patient with diabetes--and which can be used for self-learning/teaching/demonstration purposes--is highlighted.
Diabetes Nutr Metab 1999 Dec
PMID:Interactive educational diabetes simulators: future possibilities. 1078 58

The user experience with the AIDA simulator demonstrates one of the advantages of making such diabetes software readily available for free via the Internet. The comments collectively provide a picture of some of the many and varied ways in which the simulator has been applied by different users. These comments also demonstrate the potential for empowerment that some people feel can result from the use of the software. The experience with this approach is sufficiently encouraging to warrant formal evaluation studies to quantify the clinical utility of such an interactive educational diabetes simulation program. For this reason, a formal survey of 200 AIDA users (patients, relatives, and healthcare professionals) from at least 15 different countries is currently ongoing, and further formal evaluation studies in the clinic setting are planned.
Diabetes Educ
PMID:Spontaneous comments from users of the AIDA interactive educational diabetes simulator. 1114 72

AIDA is an interactive educational diabetes simulator which has been made available without charge on the Internet. Since its launch on the World Wide Web in 1996 over 58,000 people have visited the AIDA Web site (http://www.2aida.org) and over 17,500 copies of the program have been downloaded from there free-of-charge. The AIDA software is believed to be of use in recreating clinical (diabetes) situations for interactive simulation. However, despite its widespread usage, its actual utility for supporting the education of patients with Type 1 diabetes mellitus remains to be objectively demonstrated in a randomised-controlled clinical trial setting. This paper describes a prospective, randomised-controlled trial (RCT) methodology for formally evaluating the educational utility of an interactive diabetes simulator, like AIDA. The protocol makes use of two study arms, each receiving different educational interventions. During lessons, Arm A of the study will be exposed to the AIDA simulator (the active intervention), while Arm B (the control group) will benefit from conventional educational methods using standard presentations with slides and transparencies. Six lessons will be held for each study arm (one per week). At the beginning and end of the study self-monitoring blood glucose (SMBG) data will be collected, details of any hypoglycaemic episodes recorded, and assessments made of HbA1c. Participants will also be required to complete a detailed questionnaire to assess their self-confidence, quality of life and metabolic control, attitudes towards SMBG, and knowledge about insulin dosage calculation. Comparisons will be made between Arm A and Arm B using unpaired statistical analyses. A partial cross-over study design is also proposed whereby subsequently the control group will be exposed to the AIDA simulator during a further 6-week course of lessons. This will ensure that the maximum number of subjects will eventually receive the active intervention, and will also allow further within group paired analyses to be applied (with greater statistical power). An initial evaluation study using this RCT approach has just recently commenced in the Ospedale di Marino in Marino (Rome), Italy.
Diabetes Nutr Metab 2001 Feb
PMID:A randomised-controlled clinical trial methodology for evaluating the teaching utility of interactive educational diabetes simulators. 1134 61

In 1996 an interactive educational diabetes simulator called AIDA was released without charge on the Internet as a non-commercial contribution to continuing diabetes education. Over the past 4+ years over 74,000 people have visited the AIDA Web pages at http://www.2aida.org and over 20,000 copies of the program have been downloaded from there free-of-charge. This article builds on the experience gained from the AIDA development, and the World Wide Web distribution of the software, and highlights some of the problems which users have reported with the program. An updated release of the software (AIDA v4.3) is described and the method applied for modelling glycosylated haemoglobin (HbA1c) levels within this new version of AIDA is documented. An overview is provided of the trialling and beta-testing of this latest release of the program, and the general concept of a 'virtual diabetic patient' that provides an electronic representation of a patient with diabetes--and which can be used for self-learning/teaching/demonstration purposes--is highlighted.
 ...
PMID:The freeware AIDA interactive educational diabetes simulator--http://www.2aida.org--(2). Simulating glycosylated haemoglobin (HbA1c) levels in AIDA v4.3. 1138 34

In previous "Diabetes Information Technology & WebWatch" columns, various user experience with an interactive educational "virtual diabetes patient" simulator called AIDA have been documented. The simulator is available free of charge from http://www.2aida.org on the Web, and user comments that have been received to date about the program have highlighted some of the many and varied ways in which a range of people have been applying the diabetes simulations in their own particular situations and practices. Inevitably, up to now, a great deal of attention has focused on use by individuals with diabetes and their relatives, as well as by health-care professionals such as diabetologists/endocrinologists and diabetes educators. However, an important group of health-carers involved in the provision of day-to-day care for many people with diabetes are primary care physicians (general practitioners). The current "Diabetes Information Technology & WebWatch" column addresses this area, overviewing a workshop which was held in September 2000 in Italy to gain experience with application of the AIDA diabetes simulation approach as a teaching tool for general practitioners (GPs). Feedback obtained from participants attending the workshop was very positive, with GPs reporting the simulation approach to be both of interest and use. Further workshops involving other healthcare professionals--in particular, nurses--are planned.
Diabetes Technol Ther 2001
PMID:Utility of the AIDA diabetes simulator as an interactive educational teaching tool for general practitioners (primary care physicians). 1146 5

AIDA v4.0 is a freeware computer program that permits the interactive simulation of plasma insulin and blood glucose profiles for demonstration and teaching purposes. It has been made freely available, without charge, on the World Wide Web as a noncommercial contribution to continuing diabetes education. Since its Internet launch in 1996 over 23,000 people have visited the AIDA Web site (http://www.diabetic.org.uk/aida.htm) and over 7,750 copies of the program have been downloaded gratis. This report overviews the Internet release of AIDA v4.0 and provides examples of the simulator in operation. The concept of a "virtual diabetic patient" is introduced. This provides an electronic representation of a patient with diabetes that can be used for self-learning/teaching/demonstration purposes.
Diabetes Technol Ther 1999
PMID:Experience with the Internet release of AIDA v4.0--http://www.diabetic.org.uk.aida.htm--an interactive educational diabetes simulator. 1147 5

AIDA is an interactive educational diabetes simulator which has been made available without charge on the Internet. Since its launch on the World Wide Web in 1996 over 87,000 people have visited the AIDA Website--http://www.2aida.org--and over 22,000 copies of the program have been downloaded from there free-of-charge. The AIDA software is believed to be of use in recreating clinically realistic diabetes situations for interactive simulation. However, despite its widespread application, its actual utility for supporting the education of patients with type 1 diabetes mellitus remains to be objectively demonstrated in a clinical randomised controlled trial (RCT) setting. The current "Diabetes Information Technology & WebWatch" column overviews a prospective RCT methodology for formally evaluating the educational utility of an interactive diabetes simulator, like AIDA. The protocol makes use of two study arms--each receiving different educational interventions. During lessons, arm A of the study will be exposed to the AIDA simulator (the active intervention), while arm B (the control group) will benefit from conventional educational methods using standard presentations with slides and transparencies. Six lessons will be held for each study arm (one per week). At the beginning and end of the study self-monitoring blood glucose (SMBG) data will be collected, details of any hypoglycemic episodes recorded, and assessments made of glycosylated hemoglobin (HbA1c) levels. Participants will also be required to complete a detailed questionnaire to assess their self-confidence, quality of life and metabolic control, attitudes towards SMBG, and knowledge about insulin dosage calculation. Comparisons will be made between arm A and arm B using unpaired statistical analyses. A partial cross-over study design is also proposed whereby subsequently the control group will be exposed to the AIDA simulator during a further 6-week course of lessons. This will ensure that the maximum number of subjects will eventually receive the active intervention, and will also allow further within group paired analyses to be applied (with greater statistical power). This current "Diabetes Information Technology & WebWatch" column documents two of the questionnaires which are intended to be used for this RCT approach.
Diabetes Technol Ther 2001
PMID:Questionnaires for a randomized controlled trial methodology to evaluate the teaching utility of diabetes simulation programs. 1207 27

In 1996, an interactive educational diabetes simulator called AIDA was released without charge on the Internet as a noncommercial contribution to continuing diabetes education. Over the past 5 years, over 100,000 people have visited the AIDA Web pages at http://www.2aida.org and over 25,000 copies of the program have been downloaded free-of-charge. Previous Diabetes Information Technology & WebWatch columns have described various user feedback comments about the AIDA software. This current column overviews the method applied for modelling glycosylated hemoglobin (HbA1c) levels within an updated version of the AIDA program (v4.3). The result seems to be a useful and novel addition to the diabetes simulations, providing a parameter with which most users will be familiar, and able to relate. It is expected that the HbA1c indicator may prove useful in enhancing the educational value of the diabetes simulations.
Diabetes Technol Ther 2001
PMID:Simulating glycosylated hemoglobin (HbA1c) levels in diabetes using an interactive educational virtual diabetes patient simulator. 1176 26


1 2 3 Next >>